- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
191 Clinical Trials near Gulf Shores, AL
Power is an online platform that helps thousands of patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerBLU-5937 for Chronic Cough
Trial Details
Key Eligibility Criteria
975 Participants Needed
Depemokimab for Severe Asthma
Trial Details
Key Eligibility Criteria
641 Participants Needed
Tenapanor for Irritable Bowel Syndrome with Constipation
Trial Details
Key Eligibility Criteria
180 Participants Needed
Tezepelumab for COPD
Trial Details
Key Eligibility Criteria
990 Participants Needed
Enlicitide Decanoate for High Cholesterol
Trial Details
Key Eligibility Criteria
3000 Participants Needed
AR882 for Gout
Trial Details
Key Eligibility Criteria
750 Participants Needed
MK-0616 for High Cholesterol
Trial Details
Key Eligibility Criteria
14550 Participants Needed
Lorundrostat for High Blood Pressure
Trial Details
Key Eligibility Criteria
1400 Participants Needed
MK-0616 for High Cholesterol
Trial Details
Key Eligibility Criteria
2760 Participants Needed
Tenapanor for Pediatric IBS with Constipation
Trial Details
Key Eligibility Criteria
150 Participants Needed
Inclisiran for Cardiovascular Disease Prevention
Trial Details
Key Eligibility Criteria
14012 Participants Needed
Linaclotide for Pediatric Constipation
Trial Details
Key Eligibility Criteria
123 Participants Needed
Inclisiran for Cardiovascular Disease
Trial Details
Key Eligibility Criteria
17004 Participants Needed
Tanimilast Add-On Therapy for COPD
Trial Details
Key Eligibility Criteria
3980 Participants Needed
Fixed Dose Triple vs Dual Combination for COPD
Trial Details
Key Eligibility Criteria
3433 Participants Needed
Long-Term Safety of Linaclotide for Constipation
Trial Details
Key Eligibility Criteria
389 Participants Needed
Tissue Kallikrein for Ischemic Stroke
Trial Details
Key Eligibility Criteria
728 Participants Needed
Hypoglossal Nerve Stimulation for Down Syndrome
Trial Details
Key Eligibility Criteria
57 Participants Needed
Trial Details
Key Eligibility Criteria
5000 Participants Needed
Baxdrostat + Dapagliflozin for Heart Failure
Trial Details
Key Eligibility Criteria
11300 Participants Needed
Why Other Patients Applied
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
Baxdrostat + Dapagliflozin for Chronic Kidney Disease
Trial Details
Key Eligibility Criteria
2500 Participants Needed
Ziltivekimab for Heart Failure and Inflammation
Trial Details
Key Eligibility Criteria
680 Participants Needed
Ziltivekimab for Heart Attack
Trial Details
Key Eligibility Criteria
10000 Participants Needed
MK-7240 for Ulcerative Colitis
Trial Details
Key Eligibility Criteria
1020 Participants Needed
Finerenone for Heart Failure
Trial Details
Key Eligibility Criteria
2600 Participants Needed
Finerenone + Empagliflozin for Heart Failure
Trial Details
Key Eligibility Criteria
1500 Participants Needed
Pembrolizumab for Triple-Negative Breast Cancer
Trial Details
Key Eligibility Criteria
1295 Participants Needed
Asundexian for Stroke Prevention
Trial Details
Key Eligibility Criteria
12255 Participants Needed
Ziltivekimab for Heart Failure
Trial Details
Key Eligibility Criteria
5600 Participants Needed
VX-147 for Kidney Disease
Trial Details
Key Eligibility Criteria
466 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do clinical trials in Gulf Shores, AL pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do clinical trials in Gulf Shores, AL work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across trials in Gulf Shores, AL 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Gulf Shores, AL is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Gulf Shores, AL several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a medical study in Gulf Shores, AL?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest clinical trials in Gulf Shores, AL?
Most recently, we added Mirena for Endometrial Hyperplasia, RSVpreF + Shingles Vaccine for Respiratory Syncytial Virus and Tezepelumab for COPD to the Power online platform.